We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The massive vaccination campaign in Rwanda set to begin Sept. 5 is expected to cost approximately $10 million, according to the World Health Organization (WHO).
Purdue Pharma and Endo Pharmaceuticals have agreed to end the patent infringement lawsuit between them now pending in the United States District Court for the Southern District of New York concerning certain Purdue patents on OxyContin (oxycodone HCl controlled-release) Tablets.
Switzerland has become the first European country to approve Novartis and Genentech's Lucentis (ranibizumab) for the treatment of wet age-related macular degeneration, a leading cause of blindness in people over age 50.
China-based Sinovac Biotech has announced preliminary results of a Phase I clinical trial of its pandemic influenza vaccine, which was supported by China's Ministry of Science and Technology and co-developed by the company and the Chinese Centers For Disease Control and Prevention.
GlaxoSmithKline said it had received approval in 15 European countries for use of its antiviral drug Relenza in the prevention of influenza types A and B.
Global generics major Mylan Laboratories has announced it will acquire up to 71.5 percent of Mumbai-based API manufacturer Matrix's shares outstanding for $6.5 per share.